Vito Michele Garrisi Selected Research

TA protocol

1/2022

Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vito Michele Garrisi Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2012
3	Breast Neoplasms (Breast Cancer) 01/2012 - 12/2008
2	COVID-19 01/2022 - 10/2020
1	Frailty 01/2022
1	Malnutrition (Nutritional Deficiencies) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2014
1	Obesity 01/2012
1	Ductal Carcinoma 07/2009
1	Carcinogenesis 01/2008
1	Virus Diseases (Viral Diseases) 01/2008
1	Hepatocellular Carcinoma (Hepatoma) 01/2008

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 01/2022 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 07/2009 - 01/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2009 - 01/2008
1	Immunoglobulin G (IgG)IBA 05/2021
1	Immunoglobulin M (IgM)IBA 05/2021
1	Nucleic AcidsIBA 10/2020
1	AlbuminsIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	VemurafenibIBA 01/2014
1	dabrafenibIBA 01/2014
1	Blood Proteins (Serum Proteins)IBA 01/2012
1	Tumor Biomarkers (Tumor Markers)IBA 07/2009
1	SteroidsIBA 07/2009
1	Cell-Free Nucleic AcidsIBA 07/2009
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2008
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2008
1	Plasminogen Activator Inhibitor 1IBA 01/2008
1	Fetal Proteins (Fetoprotein)IBA 01/2008

Therapy/Procedure

1	TA protocol 01/2022
1	Therapeutics 01/2022
1	Drug Therapy (Chemotherapy) 01/2014